Improved techniques and supportive care have resulted in a growing number of long-term survivors of stem cell transplants, though little is known about the impact transplants have on patients’ lives long after treatment. To find the answers, researchers from the City of Hope Cancer Center and the University of Minnesota assessed 854 cancer patients that had undergone stem cell transplants, taking a detailed look at the aftereffects of the procedure in the years following the transplant. Their results will be published in the June 1, 2005, issue of Blood, the official journal of the American Society of Hematology.
All study patients had survived at least two years post-transplant, with more than 70 percent surviving through the study’s completion. The majority of study deaths occurred within five years of the transplant, but for those who survived past the fifth anniversary of their transplant, the risk of death lessened each year thereafter. Only eight deaths were recorded for those who underwent a transplant 10 years prior, and none were recorded after 15 years. In fact, for some patients – including those who had a transplant for acute myeloid leukemia and all patients with any disease who had a standard risk (as opposed to high risk) of relapse at the time of transplantation – mortality at the 10-year mark was similar to that of the general population.
Further analysis highlighted the most likely causes for death in those patients that did not survive and hinted at ways that such deaths might be minimized. For those patients who died during the study period, the main cause was a recurrence of the original disease, followed by deaths due to secondary cancers. Relapse-related mortality was increased among patients with Hodgkin’s disease, non-Hodgkin’s lymphoma, and acute lymphoblastic leukemia. However, those who had undergone total body irradiation in preparation for the transplant were at a decreased risk for relapse-related death. Mortality not related to relapse was increased in patients who had received the chemotherapy drug carmustine as part of their preparative regimen and among patients who had received a transplant with peripheral blood stem cells, as opposed to stem cells from the bone marrow.
: Laura Stark | EurekAlert!
The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences
Transforming plant cells from generalists to specialists
07.12.2016 | Duke University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine